Evaluation of the Application Status Quo of Blockchain Technology in China ’s Pharmaceutical Field
- VernacularTitle:区块链技术在我国医药领域的应用现状评价
- Author:
Chunsong YANG
1
;
Lingli ZHANG
1
;
Shan GAO
1
;
Yaya YANG
2
Author Information
1. Dept. of Pharmacy/Evidence-based Pharmacy Center，West China Second Hospital，Sichuan University，Chengdu 610041，China;Key Laboratory of Birth Defects and Related Diseases of Women and Children，Sichuan University，Ministry of Education，Chengdu 610041，China
2. Dept. of Pharmacy/Evidence-based Pharmacy Center，West China Second Hospital，Sichuan University，Chengdu 610041，China
- Publication Type:Journal Article
- Keywords:
Blockchain technology;
Pharmaceutical field;
Current situation;
Literature analysis
- From:
China Pharmacy
2020;31(17):2060-2064
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE：To evaluate t he c urrent status of the application of blockchain technology in China ’s pharmaceutical field，and to provide direction and decision support for its wide application and development in the domestic pharmaceutical field. METHODS：Retrieved from Embase ，PubMed，Cochrane library ，CBM，CNKI，VIP and Wanfang databases during the inception of databases to Sept. 30th，2019，the studies on application status of blockchain technology in China ’s pharmaceutical field were collected；descriptive analysis was conducted for research type ，publication time ，main research fields and existing problems. RESULTS & CONCLUSIONS ：A total of 60 literatures were included ，and all of them were Chinese literatures. Among them ，38 literatures were reviews ，19 were original researches ，2 were dissertation ，1 was conference paper. The publication time range was from 2016 to 2019. The application of blockchain technology in the main pharmaceutical fields is to promote the sharing of electronic medical record data ，personal health data ，clinical research data and genomic data ；the traceable path is mainly provided in medical insurance audits ，drug quality traceability and anti-counterfeiting ，medical devices and medical supplies traceability. These applications are still in the preliminary theoretical verification or trial stage. At present ，there are still some limitations or problems in the relevant policies and application standards ，data storage space and processing ，data privacy and security ，and professionals in China ’s pharmaceutical field. However ，it has high application value and potential in medical data sharing ， reducing treatment costs ， improving medical claim system ， strengthening medical management and optimizing medical decision-making.
